A fatal paediatric case infected with reassortant avian influenza A(H5N6) virus in Eastern China

• Published in: Transboundary and emerging diseases Vol. 67; no. 5; pp. 2118 - 2125
• Main Authors: Chen, Li‐Ling, Huo, Xiang, Qi, Xian, Liu, Cheng, Huang, Haodi, Yu, Huiyan, Dong, Zefeng, Deng, Fei, Peng, Jiefu, Hang, Hui, Wang, Shenjiao, Fan, Huan, Pang, Yuanyuan, Bao, Changjun
• Format: Journal Article
• Language: English
• Published: Germany Hindawi Limited 01.09.2020
• Subjects: Antibodies; Avian flu; avian influenza; Cough; fatal case; Fever; Gene sequencing; Genomes; Genotypes; H5N6; human infection; Influenza; Influenza A; Obesity; Patients; Pediatrics; Phylogeny; Polymerase chain reaction; reassortment; Respiratory distress syndrome; Respiratory tract; Reverse transcription; Viruses; Waterfowl; reassortment; avian influenza; H5N6; human infection; fatal case
• ISSN: 1865-1674; 1865-1682
• DOI: 10.1111/tbed.13561

Avian influenza A(H5N6) keeps evolving, causing outbreaks in birds and sporadic infections in human. Here, we report a fatal paediatric infection caused by a novel reassortant H5N6 virus. The patient was an obese 9‐year‐old girl. She initiated with fever and cough, then developed pneumonia, acute respiratory distress syndrome (ARDS) and respiratory failure. Lower respiratory tract aspirates and anal swabs were serially taken till the patient's death. Viral isolation, genome sequencing and phylogenetic analysis were conducted. A novel reassortant H5N6 virus was isolated from the patient. Except the PA gene, all other 7 genes of the virus belonged to H5N6 genotype A (S4‐like virus). The PA gene was probably obtained from Eurasian waterfowl influenza viruses. The H5N6 virus was consistently detected from the patient's respiratory samples till the 17th day after symptom onset, but not from anal swabs or urine sample by real‐time reverse transcription polymerase chain reaction (RT‐PCR). Significantly elevated (32‐fold) serum antibodies to H5N6 virus were observed during the patient's course of disease. Aside from the identified novel reassortant H5N6 viral strain, obesity, delayed confirmation of aetiology and specific antiviral treatment, and prolonged virus shedding could have contributed to the poor clinical outcome.